Chronic cerebral spinal venous insufficiency in multiple sclerosis

Expert Review of Neurotherapeutics

Volumn 11, Issue 1, 2011, Pages 5-9

  Haacke, E Mark ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

angioplasty; multiple sclerosis; perfusion; venous abnormalities

Indexed keywords

FREE RADICAL; HEMOSIDERIN; HYALIN; INTERCELLULAR ADHESION MOLECULE 1; IRON;

BLOOD VESSEL OCCLUSION; BRAIN DAMAGE; BRAIN HEMORRHAGE; CARDIOVASCULAR MALFORMATION; CELL DEATH; CELL MIGRATION; CEREBROSPINAL FLUID; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; COUGHING; ENCEPHALITIS; ENDOTHELIUM CELL; HEADACHE; HUMAN; IMMUNOLOGY; INTERSTITIUM; JUGULAR VEIN; LEUKOCYTE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARENCHYMA; REVIEW; TRANSITIONAL BLINDNESS; VEIN BLOOD FLOW; VEIN INSUFFICIENCY; VENOUS CIRCULATION; VENOUS REFLUX;

CEREBRAL VEINS; HUMANS; JUGULAR VEINS; MULTIPLE SCLEROSIS; PERFUSION; TIME FACTORS; VASCULAR MALFORMATIONS; VENOUS INSUFFICIENCY;

EID: 78650370382     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.174     Document Type: Review

References (47)

1. Zamboni P, Galeotti R, Menegatti E et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 80(4), 392-399 (2009).
2. Putnam T. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch. Neurol. Psychiatry 6, 1298-1321 (1937).
3. Cruveilhier J. [Pathological anatomy of the human body]. Billière, Paris, France, 2 (1829-1842).
4. Rindfleisch E. [Histological detail to the gray matter degeneration of brain and spine]. Arch. Path. Anat. Physiol. Klin. Med, 26, 474 (1863).
5. Charcot J. [Histology of sclerotic plaques]. Gaz. Hopit. Civils. Milit. 41, 554-566 (1968).
6. Putnam T. Studies in multiple sclerosis: encephalitis and sclerotic plaques produced by venular obstruction. Arch. Neurol. Psych. 33, 929-940 (1935).
7. Borst M. [Multiple sclerosis of the central nervous system]. Ergebnisse Allg. Path. Pathol. Anat. 9, 67-187 (1903).
8. Ge Y, Zohrabian VM, Osa EO et al. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J. Magn. Reson. Imaging 29(5), 1190-1194 (2009).
9. Spatz H. [Concerning the question of iron, in particular with respect to progressive paralysis]. Neurolo. u. Psychiat. 27, 171 (1921-1922).
10. Wohlwill F. [About encephalomyelitis]. Neurol. Psychiat. 112, 20 (1928).
11. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 51(2), 260-265 (1988).
12. Haacke EM, Makki M, Ge Y et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J. Magn. Reson. Imaging 29(3), 537-544 (2009).
13. Hammond KE, Metcalf M, Carvajal L et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol. 64(6), 707-713 (2008).
14. Eissa A, Lebel RM, Korzan JR et al. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting. J. Magn. Reson. Imaging 30(4), 737-742 (2009).
15. Haacke EM, Garbern J, Miao Y, Habib C, Liu M. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int. Angiol. 29(2), 149-157 (2010).
16. Simka M. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis. Curr. Neurovasc. Res. 6(2), 132-139 (2009).
17. Bergan JJ, Pascarella L, Schmid-Schonbein GW. Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J. Vasc. Surg. 47(1), 183-192 (2008).
18. Bergan JJ, Schmid-Schonbein GW, Coleridge Smith PD et al. Chronic venous disease. Minerva Cardioangiol. 55(4), 459-476 (2007).
19. Ono T, Bergan JJ, Schmid-Schonbein GW, Takase S. Monocyte infiltration into venous valves. J. Vasc. Surg. 27(1), 158-166 (1998).
20. Schelling F. Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med. Hypotheses 21(2), 141-148 (1986).
21. Carswell R. Pathological anatomy. Illustrations of the elementary forms of disease. Longman, Brown, Green and Longman, London, UK (1838).
22. Allen IV. The pathology of multiple sclerosis-fact, fiction and hypothesis. Neuropathol. Appl. Neurobiol. 7(3), 169-182 (1981).
23. Fog T. On the vessel-plaque relations in the brain in multiple sclerosis. Acta Neurol. Scand. Suppl. 39(Suppl. 4), 258-262 (1963).
24. Fog T. Rygmarvens patologiske anatomi. Munkgaards, Copenhagen, Denmark (1948).
25. Juurlink BH. The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated? Med. Hypotheses 51(4), 299-303 (1998).
26. Swank RL, Roth JG, Woody DC Jr. Cerebral blood flow and red cell delivery in normal subjects and in multiple sclerosis. Neurol. Res. 5(1), 37-59 (1983).
27. Law M, Saindane AM, Ge Y et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231(3), 645-652 (2004).
28. Ge Y, Law M, Johnson G et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am. J. Neuroradiol. 26(6), 1539-1547 (2005).
29. Adhya S, Johnson G, Herbert J et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33(4), 1029-1035 (2006).
30. Varga AW, Johnson G, Babb JS et al. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J. Neurol. Sci. 282(1-2), 28-33 (2009).
31. Rashid W, Parkes LM, Ingle GT et al. Abnormalities of cerebral perfusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75(9), 1288-1293 (2004).
32. Yamada K, Gonzalez RG, ØStergaard L et al. Iron-induced susceptibility effect at the globus pallidus causes underestimation of flow and volume on dynamic susceptibility contrast-enhanced MR perfusion images. AJNR Am. J. Neuroradiol. 23(6), 1022-1029 (2002).
33. Inglese M, Park SJ, Johnson G et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch. Neurol. 64(2), 196-202 (2007).
34. Haselhorst R, Kappos L, Bilecen D et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J. Magn. Reson. Imaging 11(5), 495-505 (2000).
35. Lightman S, McDonald WI, Bird AC et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 110(Pt 2), 405-414 (1987).
36. Lee AB, Laredo J, Neville R. Embryological background of truncular venous malformation in the extracranial venous pathways as the cause of chronic cerebro spinal venous insufficiency. Int. Angiol. 29(2), 95-108 (2010).
37. Chung CP, Hu HW. Jugular venous reflux. J. Med. Ultrasound 16, 210-222 (2008).
38. Harvey W. Cardiac Classics. C.V. Mosby, MO, USA, 19 (1941).
39. Lewis SL. Aetiology of transient global amnesia. Lancet 352(9125), 397-399 (1998).
40. Hsu HY, Chao AC, Chen YY et al. Reflux of jugular and retrobulbar venous flow in transient monocular blindness. Ann. Neurol. 63(2), 247-253 (2008).
41. Chuang YM, Hu HH. Cough headache and thoracic inlet valvular competence in uremia. Eur. Neurol. 53(2), 78-80 (2005).
42. Doepp F, Valdueza JM, Schreiber SJ. Incompetence of internal jugular valve in patients with primary exertional headache: a risk factor? Cephalalgia 28(2), 182-185 (2008).
43. Farb RI, Vanek I, Scott JN et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60, 1418-1424 (2003).
44. Agid R, Shelef I, Scott JN, Farb RI. Imaging of the intracranial venous system. Neurologist 14(1), 12-22 (2008).
45. Zamboni P, Menegatti E, Bartolomei I et al. Intracranial venous haemodynamics in multiple sclerosis. Curr. Neurovasc. Res. 4(4), 252-258 (2007).
46. Ludyga T, Kazibudzki M, Simka S. Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Endovasc. Ther. (2010) (In press).
47. Minagar A, Jy W, Jimenez JJ, Alexander JS. Multiple sclerosis as a vascular disease. Neurol. Res. 28(3), 230-235 (2006).